(Q39131201)
Statements
1 reference
Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties (English)
Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties (English)
Danneskiold-Samsoe P
1 reference
A. V. Christensen
B. Fjalland
V. Pedersen
P. Danneskiold-Samsoe
1 January 1977
1 reference
1 reference
41
1 reference
2
1 reference
153-162
1 reference
14
277
Indolamine metabolism in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline (English)
Åsberg
1973
5
367
Effect of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4, α-dimethyl meta-tyramine (English)
Carlsson
1969
5
357
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine (English)
Carlsson
1969
12
456
Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine (English)
Carlsson
1969
Neurochemical characterization of a new potent and selective serotomin uptake inhibitor, Lu 10–171 (English)
Hyttel
1977
19
112
Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice (English)
Hyttel
1972
24
121
Pharmacological studies of a new series of bicyclic thymoleptics (English)
Petersen
1966
28
241
Further pharmacological studies of bicyclic thymoleptics (English)
Petersen
1970
19
148
Endogenous depression with and without disturbance in the 5-hydroxytryptamine metabolism: a new biochemical classification (English)
Van Praag
1971
1 reference
Identifiers
1 reference
1 reference